Advanced Solid Malignancies Terminated Phase 1 Trials for Urelumab (DB12077)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00351325A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid MalignanciesTreatment